Peter Rudge

Peter Rudge's AcademicInfluence.com Rankings

Peter Rudge

Philosophy

#7953

World Rank

#11241

Historical Rank

Logic

#4984

World Rank

#6333

Historical Rank

philosophy Degrees

Peter Rudge

Biology

#10718

World Rank

#14071

Historical Rank

Neuroscience

#1682

World Rank

#1734

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Peter Rudge's Degrees

PhD Neuroscience University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Peter Rudge Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Rudge's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. (1990) (592)
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. (1998) (494)
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. (1987) (491)
In vivo cellular tropism of human T-cell leukemia virus type 1 (1990) (435)
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. (1988) (416)
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy (2015) (392)
Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis (1994) (337)
Visual vertigo: symptom assessment, spatial orientation and postural control. (2001) (317)
Abnormalities of the auditory evoked potentials in patients with multiple sclerosis. (1977) (302)
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis (1995) (243)
REVIEW ARTICLESuperficial siderosis of the central nervous system (1995) (239)
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trial (1997) (237)
Positional down beating nystagmus in 50 patients: cerebellar disorders and possible anterior semicircular canalithiasis (2002) (228)
Heterogeneity of blood‐brain barrier changes in multiple sclerosis (1990) (219)
Neurological complications in Behçet's syndrome. (1999) (215)
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis (1997) (202)
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial (2009) (201)
Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. (1982) (197)
Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance (1996) (191)
Long-term retrograde amnesia… the crucial role of the hippocampus (2001) (191)
Treatment of periodic alternating nystagmus (1980) (173)
Bilateral loss of vestibular function: clinical findings in 53 patients (1998) (165)
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. (2001) (164)
Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. (1987) (161)
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay (2011) (159)
Downbeating nystagmus. A review of 62 cases. (1983) (159)
Phobic postural vertigo (1997) (158)
Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. (1992) (155)
A study of oligoclonal band negative multiple sclerosis. (1996) (152)
Primary position upbeating nystagmus. A variety of central positional nystagmus. (1983) (152)
IMMUNOTHERAPY-RESPONSIVE SEIZURE-LIKE EPISODES WITH POTASSIUM CHANNEL ANTIBODIES (2008) (140)
Magnetic resonance imaging in isolated noncompressive spinal cord syndromes (1987) (133)
Encephalomyelitis in primary hypogammaglobulinaemia. (1996) (131)
Acute myelopathy associated with primary infection with human immunodeficiency virus. (1987) (126)
The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients. (1990) (124)
Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. (1989) (123)
Recollection and familiarity in dense hippocampal amnesia: A case study (2006) (122)
Variant CJD in an individual heterozygous for PRNP codon 129 (2009) (119)
PARADOXICAL EXPANSION OF INTRACRANIAL TUBERCULOMAS DURING CHEMOTHERAPY (1984) (117)
Effect of Lamivudine on Human T-Cell Leukemia Virus Type 1 (HTLV-1) DNA Copy Number, T-Cell Phenotype, and Anti-Tax Cytotoxic T-Cell Frequency in Patients with HTLV-1-Associated Myelopathy (1999) (115)
The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord (1989) (113)
Brain biopsy in dementia. (2005) (110)
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial (2006) (109)
ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 IN WEST-INDIAN-BORN UK RESIDENTS WITH SPASTIC PARAPARESIS (1987) (109)
Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129. (2017) (108)
Magnetic resonance imaging in clinically isolated lesions of the brain stem. (1986) (106)
A novel prion disease associated with diarrhea and autonomic neuropathy. (2013) (105)
AUDITORY EVOKED RESPONSES IN MULTIPLE SCLEROSIS (1975) (101)
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone (2018) (100)
Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. (1996) (97)
Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis (1978) (94)
Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. II. Gaze palsy and internuclear ophthalmoplegia. (1990) (93)
Acute peripheral nerve compression in the baboon. (1974) (91)
Bilateral lesions of CA1 and CA2 fields of the hippocampus are sufficient to cause a severe amnesic syndrome in humans. (1995) (91)
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years (2015) (90)
Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. (1979) (90)
Randomised double blind controlled trial of cyclosporin in multiple sclerosis. (1989) (83)
Tourniquet paralysis with prolonged conduction block. An electro-physiological study. (1974) (82)
Magnetic resonance imaging of the central nervous system in Behçet's disease. (1993) (77)
Tau, prions and Aβ: the triad of neurodegeneration (2010) (77)
The effects of thallium salts, with particular reference to the nervous system changes. A report of three cases. (1974) (77)
DOUBLE-BLIND CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN THE TREATMENT OF MULTIPLE SCLEROSIS: FINAL REPORT (1982) (76)
Are multiplication facts implemented by the left supramarginal and angular gyri? (2002) (76)
Cognitive and social impairments in patients with superficial siderosis. (2005) (72)
Imaging and CSF analyses effectively distinguish CJD from its mimics (2017) (66)
Dissociation of visual and haptic vertical in two patients with vestibular nuclear lesions (2003) (66)
Torsional nystagmus. A neuro-otological and MRI study of thirty-five cases. (1992) (66)
CJD mimics and chameleons (2017) (64)
MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis (2004) (64)
Ocular inflammatory changes in established multiple sclerosis. (1989) (63)
MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease (2012) (63)
The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. (2013) (63)
Infratentorial superficial siderosis: Classification, diagnostic criteria, and rational investigation pathway (2017) (62)
Down beating nystagmus: Magnetic resonance imaging and neuro-otological findings (1987) (59)
Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. (2002) (58)
Vestibular involvement in spasmodic torticollis. (1986) (57)
Diagnosis of enterovirus brain disease in hypogammaglobulinemic patients by polymerase chain reaction. (1993) (57)
The stability of the auditory evoked potentials in normal man and patients with multiple sclerosis (1978) (55)
Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta (2008) (55)
Analysis of downbeat nystagmus. Otolithic vs semicircular canal influences. (1986) (55)
The use of the auditory evoked potential in the diagnosis of multiple sclerosis (1980) (55)
The inner ear and the neurologist (2007) (54)
Bilateral loss of vestibular function. (1995) (54)
Neuro-otological abnormalities in Friedreich's ataxia. (1984) (54)
Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation. (2016) (53)
Testing the gate-control theory of pain in man P. W. Nathan and P. Rudge, J. Neurol. Neurosurg. Psychiat., 37 (1974) 1366–1372 (1974) (51)
NMR IN MULTIPLE SCLEROSIS AND CEREBRAL VASCULAR DISEASE (1984) (49)
High-b-Value Diffusion MR Imaging and Basal Nuclei Apparent Diffusion Coefficient Measurements in Variant and Sporadic Creutzfeldt-Jakob Disease (2010) (49)
Congenital‐type nystagmus emerging in later life (1991) (48)
The site of brainstem lesions causing semicircular canal paresis: an MRI study. (1992) (47)
Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre (2003) (46)
Brain stem encephalitis caused by Herpesvirus hominis. (1972) (45)
Does a retrovirally encoded superantigen cause multiple sclerosis? (1991) (43)
Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. I. Abducens palsy. (1990) (43)
Hyperpathia in the central cervical cord syndrome (1973) (42)
PCR Analysis of DNA from Multiple Sclerosis Patients for the Presence of HTLV-I (1989) (42)
Gaze failure, drifting eye movements, and centripetal nystagmus in cerebellar disease. (1977) (42)
Sequential changes in oligoclonal patterns during the course of multiple sclerosis. (1983) (42)
Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease (2014) (41)
Multiple sclerosis, tropical spastic paraparesis and HTLV-1 infection in Afro-Caribbean patients in the United Kingdom. (1991) (41)
Foreign accent syndrome, speech rhythm and the functional neuronatomy of speech production (2006) (39)
Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type‐1 (HTLV‐1); enhanced lymphocytic proliferation and tropical spastic paraparesis (1993) (39)
The Tullio phenomenon: a neurologically neglected presentation (2011) (39)
Auditory function in hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease). (1987) (39)
Dendritic cells in HIV-1 and HTLV-1 infection. (1993) (38)
Neuralgic amyotrophy due to parvovirus infection. (1987) (37)
Behavioral and psychiatric symptoms in prion disease. (2014) (36)
Autoantibodies in sporadic Creutzfeldt-Jakob disease. (2013) (36)
Neuro-otological abnormalities in xeroderma pigmentosum with particular reference to deafness. (1985) (36)
Oligodendroglial gliomatosis cerebri: 1H-MRS suggests elevated glycine/inositol levels (1999) (36)
HTLV-I infection and neurological disease in Rio de Janeiro. (1992) (36)
Effects of anti‐CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production (1997) (35)
Malignant angioendotheliosis involving the nervous system: support for a lymphoid origin of the neoplastic cells. (1987) (34)
Wave form analysis of the brain stem auditory evoked potential. (1981) (33)
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease. (2016) (33)
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides (1991) (33)
Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. (1990) (31)
The effect of adult-acquired hippocampal damage on memory retrieval: An fMRI study (2005) (31)
Somnolence associated with melatonin deficiency after pinealectomy (1996) (30)
Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus (1992) (30)
Tropical spastic paraparesis and human T-cell lymphotropic virus type 1. (1990) (30)
Vestibular, cervical and visual remembered saccades in Parkinson's disease. (1994) (29)
The site of the lesion causing deafness in multiple sclerosis. (1988) (29)
Does interferon beta cause initial exacerbation of multiple sclerosis? (1995) (28)
The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis (2000) (28)
Convergence nystagmus associated with Arnold-Chiari malformation. (1990) (28)
DOUBLE-BLIND, CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN TREATMENT OF MULTIPLE SCLEROSIS (1980) (28)
HTLV-I associated primary CNS T-cell lymphoma (1998) (28)
Leucocyte proteinase activity and acute multiple sclerosis (1975) (27)
Hippocampal, but not parahippocampal, damage in a case of dense retrograde amnesia: a pathological study (2002) (26)
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases (2020) (25)
Does the Left Inferior Parietal Lobule Contribute to Multiplication Facts? (2005) (25)
Axonal velocities of motor units in the hand and foot muscles of the baboon (1976) (25)
Late onset post-traumatic hypothalamic hypothermia (1983) (24)
Intrathecal baclofen pump infection treated by adjunct intrareservoir antibiotic instillation. (1994) (24)
PRION-1 scales analysis supports use of functional outcome measures in prion disease (2011) (24)
Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients. (1987) (23)
Late recurrences of Sydenham’s chorea are not associated with anti-basal ganglia antibodies (2004) (23)
Tardive dyskinesia presenting as severe dysphagia. (1992) (23)
Hemiparetic multiple sclerosis. (1990) (23)
Cerebral venous thrombosis and subarachnoid haemorrhage in users of oral contraceptives. (1986) (23)
Lymphomatosis cerebri presenting as a rapidly progressive dementia with a high methylmalonic acid (2011) (22)
Analysis of a case of periodic alternating nystagmus. (1976) (22)
Loffler's eosinophilic endocarditis with Balint's syndrome (optic ataxia and paralysis of visual fixation). (1971) (22)
The cognitive profile of prion disease: a prospective clinical and imaging study (2015) (22)
Central and peripheral SEP defects in neurologically symptomatic and asymptomatic subjects with low vitamin B12 levels (1987) (21)
Identification without naming: a functional neuroimaging study of an anomic patient (2001) (21)
Familial multiple sclerosis (1988) (21)
Visually and memory guided saccades in a case of cerebellar saccadic dysmetria. (1994) (21)
The cause of nerve damage in acute compression. (1974) (21)
The differential diagnosis of cerebello-pontine angle lesions A multidisciplinary approach with special emphasis on the brainstem auditory evoked potential (1983) (20)
Reversible parkinsonism following heroin pyrolysate inhalation is associated with tetrahydrobiopterin deficiency (2004) (20)
Spinal cord sarcoidosis with intramedullary cyst formation. (1990) (20)
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme (2022) (20)
Quantitative EEG parameters correlate with the progression of human prion diseases (2016) (20)
Auditory deficits and hearing loss associated with focal brainstem haemorrhage. (1996) (19)
Three patients with migraine following caloric-induced vestibular stimulation (2006) (19)
Predictive testing for inherited prion disease: report of 22 years experience (2014) (19)
Investigations of disorders of balance. (1995) (19)
Are clinical trials of therapeutic agents for MS long enough? (1999) (19)
Paroxysmal alternating skew deviation and nystagmus after partial destruction of the uvula (2001) (18)
Spasmodic torticollis following unilateral VIII nerve lesions: neck EMG modulation in response to vestibular stimuli. (1987) (18)
Moebius syndrome, an axonal neuropathy and hypogonadism (1996) (18)
On the role of sensitised T-lymphocytes in the pathogenesis of multiple sclerosis (1980) (17)
The effect of multiple sclerosis on pure tone thresholds. (1984) (17)
Acquired pendular nystagmus suppressed by alcohol (1993) (17)
The Facial Palsies (1981) (15)
Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation (2010) (15)
Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals (1992) (15)
Methylprednisolone therapy in tropical spastic paraparesis. (1990) (15)
MAGNETIC-RESONANCE-IMAGING OF THE CENTRAL-NERVOUS-SYSTEM IN BEHCETS-DISEASE (1993) (15)
The vestibular system in abnormal head postures and in spasmodic torticollis. (1988) (14)
Optic Neuritis as a Complication of Carcinoma of the Breast (1973) (14)
Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy‐like syndrome (2003) (14)
Syncope associated with pain as the presenting feature of neck malignancy: failure of cardiac pacemaker to prevent attacks in two cases (2005) (14)
The effects on auditory function of damage to the pontine olivo-cochlear bundle in man. (1988) (14)
Autosomal dominant late onset cerebellar ataxia with myoclonus, peripheral neuropathy and sensorineural deafness: a clinicopathological report. (1984) (14)
Acquired pendular nystagmus: oculomotor and MRI findings. (1995) (13)
MRI of thoracic cord in tropical spastic paraparesis. (1990) (13)
Clinical neuro-otology (1983) (13)
The cerebral pathways of optokinetic nystagmus: a neuro-anatomical study. (1975) (12)
Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases. (2010) (12)
Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease (2019) (12)
The neurourology of tropical spastic paraparesis. (1991) (12)
A survey of the pattern reversal visual evoked response (PRVER) in 1428 consecutive patients referred to a clinical neurophysiology department (1984) (11)
An unusual case of X-linked adrenoleukodystrophy with auditory processing difficulties as the first and sole clinical manifestation. (2004) (11)
Cyclosporine and multiple sclerosis: The cons (1988) (11)
Proceeding: The site of conduction block in peripheral nerves compressed by a pneumatic tourniquet. (1974) (10)
11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt–Jakob disease (2011) (9)
Spatz-Lindenberg disease: a rare cause of vascular dementia. (1999) (9)
Multiparameter MR Imaging in the 6-OPRI Variant of Inherited Prion Disease (2013) (9)
Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study (2016) (9)
Double-blind, placebo-controlled, MR monitored exploratory trial of chimeric anti-CD4 antibodies in MS. (1995) (8)
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases (2013) (8)
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission (2021) (8)
The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature (2018) (7)
MAGNETIC RESONANCE IMAGING IN HTLV-1 ANTIBODY POSITIVE PATIENTS (1987) (7)
Erratum: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy (2015) (7)
The value of natural history studies of multiple sclerosis. (1999) (6)
Fundamentals of Sensorineural Auditory Pathology (1977) (6)
Peripheral neuropathy in baboons. (1975) (6)
Cyclosporin A curtails the progression of free light chain synthesis in the CSF of patients with multiple sclerosis. (1989) (6)
Viral specific IgG and IgM antibodies in the CSF of patients with tropical spastic paraparesis (1989) (6)
Use of PCR to Investigate the Cellular Tropism of Human T Cell Leukemia Virus Type 1 (1991) (5)
The Use of Ciclosporin (CyA) in Multiple Sclerosis — Trial Design and Tolerance (1985) (5)
The most problematic symptoms of prion disease – an analysis of carer experiences (2018) (5)
Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1 (2012) (5)
Comment on validation of diagnostic criteria for variant Creutzfeldt‐Jakob disease (2011) (4)
Primary position upbeating nystagmus associated with middle ear disease (1988) (4)
A novel prion protein variant in a patient with semantic dementia (2017) (4)
A case of Noonan's syndrome and hypoparathyroidism presenting with epilepsy (1974) (4)
A 38-year-old man with a 9 month history of neurological and cognitive impairment (2003) (4)
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon (2022) (4)
Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease (2020) (4)
Treatment of superficial siderosis of the central nervous system. (1995) (4)
HTLV-1 associated primary CNS T-cell lymphoma (vol 158, pg 226, 1998) (1999) (4)
Auditory evoked potentials in man — Psychopharmacology correlates of EPs (Progress in clinical neurophysiology, vol. 2), by J. E. Desmedt (ed.), viii + 212 pages, 81 illustrations, 12 tables, S. Karger, Basel, 1977, Sfr/DM 98.00, US$ 37.75 (1978) (3)
Hyperpathia inthecentral cervical cordsyndrome (1973) (3)
Assessing initial MRI reports for suspected CJD patients (2022) (3)
Myelopathy associated with human T cell lymphotropic virus type 1 in a white European native to England. (1992) (3)
Clinical Neurology—A Review (1989) (3)
LETTERS TO THE EDITOR (1990) (3)
Central motor conduction studies in tropical spastic paraparesis (TSP) (1990) (3)
CONVERGENCE NYSTAGMUS ASSOCIATED WITH ARNOLD-CHIARI MALFORMATION. AUTHORS'REPLY (1991) (3)
Genome-wide association study of behavioural and psychiatric features in human prion disease (2015) (3)
Corrective saccades in cerebellar dysmetria (1995) (3)
Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study (2022) (3)
Estimation of the number of inherited prion disease mutation carriers in the UK (2022) (2)
Anaemia with Inappropriately Low Erythropoietin in a New Autonomic and Sensory Neuropathy Attributed to Nerve Growth Factor Deficiency (1991) (2)
Collinge et al. reply (2016) (2)
Neuro-otological assessment in the patient with balance and gait disorder (2004) (2)
ONE‐AND‐A‐HALF SYNDROME RESULTING FROM SPONTANEOUS VERTEBRAL ARTERY DISSECTION (2002) (2)
Treatment of Multiple Sclerosis with Intravenous Immunoglobulin (2001) (2)
Enteral feeding is associated with longer survival in the advanced stages of prion disease (2019) (2)
Clinical trials and methodological problems in prion diseases Reply (2009) (2)
Chapter 12 Conventional Immunosuppression and Multiple Sclerosis (2003) (1)
Creutzfeld-Jakob disease--reply. (2013) (1)
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases (2013) (1)
Clinical trials and methodological problems in prion diseases – Authors' reply (2009) (1)
Letters to the editor (1995) (1)
Longitudinal VBM of regional progression in human prion disease (2012) (1)
Video Rating in Neurodegenerative Disease Clinical Trials (2012) (1)
Sequential changes inoligoclonal patterns during the courseofmultiple sclerosis (1983) (1)
Tropical Spastic Paraparesis & HTLV-1: Viral Prevalence among Relatives of UK Patients in Britain & Jamaica (1988) (1)
Multiple Sclerosis in Childhood, Diagnosis and Prophylaxis (1981) (1)
Focal dystonia secondary to superficial siderosis (1996) (1)
Development of prognostic models for survival and care status in sporadic Creutzfeldt-Jakob disease (2022) (1)
The effect of cyclosporin A on IL-2 receptor expression and IL-2 production both in vivo and in vitro (1987) (0)
Changing activity in MS lesions: An MRI study (1989) (0)
HTLVl associated primary cerebral T cell lymphoma (1996) (0)
Vestibular Neurotology (Advances in Oto-Rhino-Laryngology 28) (1983) (0)
MULTIPLE SCLEROSIS TRIALS. AUTHOR'S REPLY (1999) (0)
Seeds of neuroendocrine doubt Reply (2016) (0)
POD04 Analysis of eight rating scales supports the use of functional outcome measures in prion disease clinical trials: experience from the PRION-1 trial and the National Prion Monitoring cohort (2010) (0)
Prion protein-induced tau phosphorylation: insight into a universal mechanism triggered by cerebral amyloid (2011) (0)
Randomised Trial of Oral and Intravenous Methyl-prednisolone in Acute Relapses of Multiple Sclerosis (1998) (0)
Prion disease masquerading as Alzheimer's disease (2011) (0)
Neutralising antibodies to interferon beta are associated with loss of efficacy of treatment and reduced side effects (2007) (0)
Vestibular Disorders (1989) (0)
A novel neurodegenerative disease with multi-system features (2022) (0)
MR IMAGING (MRI) IN ISOLATED NEUROLOGICAL LESIONS (1986) (0)
Trajectories of neurodegeneration and seed amplification biomarkers prior to disease onset in individuals at risk of prion disease (2022) (0)
Prion diseases: John Collinge and Mark S. Palmer (Eds.) (Oxford University Press, 1997, price: £29.95) (1997) (0)
spastic paraparesis . Methylprednisolone therapy in tropical (0)
Clinical Neuro-Imaging (1988) (0)
Contents of the American Journal of Psychiatry (2014) (0)
Multiple sclerosis trials (1999) (0)
Interferon beta 1b (1994) (0)
Magnetic resonanceimaging inclinically isolated lesions ofthebrain stem (1986) (0)
multiple sclerosis . patterns during the course of Sequential changes in oligoclonal (0)
Cognitive decline heralds onset of symptomatic inherited prion disease (2020) (0)
British specialist multiple sclerosis centre Interferon beta in multiple sclerosis: experience in a (2008) (0)
Interferon antibodies: do they alter the beneficial effects of beta-interferon upon relapse rate in multiple sclerosis? (2004) (0)
Collinge et al. reply (2016) (0)
Multicenter double-blind controlled trial of cyclosporine in multiple sclerosis (1988) (0)
POD01 Misleading MRI in two recent patients with variant Creutzfeldt–Jakob disease emphasises the importance of tissue diagnosis (2010) (0)
Subacute sclerosing panencephalitis: rapidly progressive cognitive decline in a young patient. (2013) (0)
Brain biopsy in dementia: A review of 90 consecutive cases from Queen Square (2005) (0)
THE NATIONAL PRION MONITORING COHORT: A LONGITUDINAL OBSERVATIONAL STUDY OF UK HUMAN PRION INFECTION (2009) (0)
COMPARISON BETWEEN TROPICAL SPASTIC PARAPARESIS AND MULTIPLE-SCLEROSIS USING EVOKED-POTENTIALS, MRI SCANNING AND HTLVI ANTIBODY ANALYSIS (1988) (0)
POD03 Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation (2010) (0)
The Effect of Acute Compression on Nerve Conduction — a Quantitative Study1 (1975) (0)
Possible evidence of human transmission of amyloid beta pathology (2016) (0)
Sequential changes in oligoclonal patterns during the course of multiple sclerosis. (1983) (0)
A Novel Prion Disease Presenting with Diarrhea and Autonomic Neuropathy (2013) (0)
Variant or sporadic Creutzfeldt-Jakob disease? – Authors' reply (2010) (0)
MULTI-PARAMETER MRI ANALYSIS IN THE NATIONAL PRION COHORT (2014) (0)
Pathologically confirmed variant CJD in a prion protein gene codon 129 heterozygous patient (2017) (0)
Optic Neuritis and its Differential Diagnosis (1980) (0)
Evaluation of anti-interferon beta neutralising antibodies in subjects with relapsing multiple sclerosis (2007) (0)
Variant or sporadic Creutzfeldt-Jakob disease? reply (2010) (0)
Multiple sclerosis - an autoimmune and/or virus related disease? (1992) (0)
022 Voxelwise analysis of cerebral diffusion tensor imaging in prion diseases (2012) (0)
Putaminal diffusion tensor imaging measures predict disease severity across human prion diseases (2020) (0)
Multifocal cortical myoclonus and cerebral amyloid β-peptide angiopathy (1998) (0)
Testing thegate-control theory ofpaininman (1974) (0)
Stratified medicine approach in sporadic Creutzfeldt-Jakob disease greatly increases power in simulated clinical trials (2014) (0)
Perspective on emerging treatments for MS (1995) (0)
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease. (2023) (0)
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone (2018) (0)
dysphagia . Tardive dyskinesia presenting as severe (0)
An Elderly Man with Cranial Nerve Palsies, Otalgia and Otorrhoea (2004) (0)
Evaluation of anti-interferon beta antibodies in subjects with multiple sclerosis attending the national hospital for neurology and neurosurgery, London (2007) (0)
ORIGINAL RESEARCH High-b-Value Diffusion MR Imaging and Basal Nuclei Apparent Diffusion Coefficient Measurements in Variant and Sporadic Creutzfeldt-Jakob Disease (2010) (0)
Voxel-based analysis of high-and standard b-value diffusion weighted imaging and voxel-based morphometry in inherited prion disease (2009) (0)
Comments on 'Patterns of Auditory Abnormality in Multiple Sclerosis' by Jerger et al. [1986]: Correspondence (2009) (0)
PAW23 Voxel-based analysis of magnetisation transfer ratio as a potential biomarker in prion diseases (2010) (0)
Voxel-based T 2 Relaxometry in Prion Disease (2010) (0)
A fourth ventricular papilloma presenting with transient autonomic failure (1999) (0)

This paper list is powered by the following services:

Peter Rudge's Academic­Influence.com Rankings

Peter Rudge's Degrees

Why Is Peter Rudge Influential?

Peter Rudge's Published Works

Published Works

Peter Rudge's AcademicInfluence.com Rankings